Assessing Substances Abuse-Induced Mortality Rates by Autopsy Method in Iran
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 11 No. 2 (2021),
15 June 2021
Background: Substance abuse is among the main causes of preventable diseases and premature deaths worldwide. Despite legal efforts to prevent substance abuse, it has increased and imposed significant economic costs on societies. This analytical cross-sectional study aimed to explore the rate of substance abuse-induced mortality in the provinces of Iran, in 2017. We elaborated an evaluation structure to identify nationwide different substance abuse-related mortality rates.
Methods: We employed the retrospective data extracted from autopsy, forensic medicine examination, and demographic characteristics from the recordings in the Iranian Legal Medicine Organization (ILMO). Stata and ArcGIS were applied for data analysis.
Results: Nationwide, 3089 substance abuse-related deaths were recorded in the ILMO; the incidence rate was 38.17 per million subjects. The deaths mostly occurred in the 30-39 age group and males accounted for 90% of cases. The provinces of Kermanshah, Lorestan, Fars, Hamadan, and Semnan reported significantly higher rates, compared with the provinces of Mazandaran, West-Azerbaijan, and Golestan with the lowest mortality rates per million (74.72, 69.81, 63.42, 61.70, 58.53 vs. 10.82, 12.11, 14.30, respectively). Mortality rates due to the abuse of methadone (20.29), morphine (12.34), amphetamine (5.32), methamphetamine (7.05), codeine (4.21), tramadol (5.96), benzodiazepine (1.47), and diphenoxylate (0.05) were calculated per million populations of Iran.
Conclusion: The obtained data suggested that preventive interventions should focus on the 20-40 age group. Methadone, morphine, and methamphetamine were associated with the highest mortality, compared to other substances; thus, they require effective treatment and preventive programs. Iranian Drug Control Headquarters, police department, and policymakers should act more efficiently regarding a preventive strategic plan in this respect.
- Death Rate, Substance abuse, Autopsy, Toxicology, Iran
How to Cite
McVicar D, Moschion J, van Ours JC. Early illicit drug use and the age of onset of homelessness. J R Stat Soc Ser A. 2019; 182(1):345-72. [DOI:10.1111/rssa.12411]
Galea S, Nandi A, Vlahov D. The social epidemiology of substance use. Epidemiol Rev. 2004; 26(1):36-52. [DOI:10.1093/epirev/mxh007] [PMID]
World Health Organization (WHO). Global Information System on Alcohol and Health (GISAH) [Internet]. 2021 Available from: https://www.who.int/gho/alcohol/en/.
World Health Organization (WHO). Age-standardized prevalence of tobacco smoking among persons 15 years and older (%), by WHO region, 2016 [Internet]. 2016 [Updated 2018 March 23]. Available from: http://apps.who.int/gho/data/node.sdg.3-a-viz?lang=en.
Institute for Health Metrics and Evaluation (IHME). Opioid deaths in US [Internet]. 2018 [Updated 2018 May 8]. Available from: http://www.healthdata.org/infographic/opioid-deaths-us.
GBD. GBD Compare [Internet]. 2019. Available from: https://vizhub.healthdata.org/gbd-compare/.
Razzaghi EM, Rahimi A, Hosseni M, Madani S. Rapid Situation Assessment (Rsa) Of Drug Abuse in Iran (1998-1999) [Internet]. 1999 [Updated No Date]. Available from: https://www.unodc.org/documents/islamicrepublicofiran/publications/RSA2000SUMMARY.pdf
Institute for Health Metrics and Evaluation (IHME). What risk factors drive the most death and disability combined? [Internet]. 2019. Available from: http://www.healthdata.org/iran
Mokri A. Brief overview of the status of Substance abuse in Iran. Archives of Iranian Medicine. 2002; 5(3):184-90. https://www.sid.ir/En/Journal/ViewPaper.aspx?ID=13073
Shahbazi F, Mirtorabi D, Ghadirzadeh MR, Hashemi-Nazari SS. Analysis of mortality rate of illicit substance abuse and its trend in five years in Iran, 2014-2018. Addict Health. 2018;10(4):260-8. [DOI:10.22122/ahj.v10i4.602] [PMID] [PMCID]
Ghoreishi SMS, Shahbazi F, Mirtorabi SD, Ghadirzadeh MR, Hashemi Nazari SS. Epidemiological study of mortality rate from alcohol and illicit drug abuse in Iran. J Res Health Sci. 2017; 17(4):e00395. [PMID]
World Health Organization (WHO). Resources for the prevention and treatment of substance use disorders [Internet]. 2021. Available from: https://www.who.int/gho/substance_abuse/en/.
Jones AW, Holmgren A, Ahlner J. Blood methadone concentrations in living and deceased persons: Variations over time, subject demographics, and relevance of coingested drugs. J Anal Toxicol. 2012; 36(1):12-8. [DOI:10.1093/jat/bkr013] [PMID]
Lev R, Petro S, Lee A, Lee O, Lucas J, Castillo EM, et al. Methadone related deaths compared to all prescription related deaths. Forensic Sci Int. 2015; 257:347-52. [DOI:10.1016/j.forsciint.2015.09.021] [PMID]
Petrushevska T, Jakovski Z, Poposka V, Stefanovska VV. Drug-related deaths between 2002 and 2013 with accent to methadone and benzodiazepines. J Forensic Leg Med. 2015; 31:12-8. [DOI:10.1016/j.jflm.2014.12.013] [PMID]
Akhgari M, Mobaraki H, Etemadi-Aleagha A. Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths. Daru J Pharm Sci. 2017; 25(1):5. [DOI:10.1186/s40199-017-0170-4] [PMID] [PMCID]
Kordrostami R, Akhgari M, Ameri M, Ghadipasha M, Aghakhani K. Forensic toxicology analysis of self-poisoning suicidal deaths in Tehran, Iran; Trends between 2011-2015. Daru J Pharm Sci. 2017; 25(1):15. [DOI:10.1186/s40199-017-0181-1] [PMID] [PMCID]
Stringer KL, Baker EH. Stigma as a barrier to substance abuse treatment among those with unmet need: An analysis of parenthood and marital status. J Fam Issues. 2018; 39(1):3-27. [DOI:10.1177/0192513X15581659] [PMID] [PMCID]
Mijatović V, Samojlik I, Ajduković N, Đurendić‐Brenesel M, Petković S. Methadone‐related deaths-epidemiological, pathohistological, and toxicological traits in 10‐year retrospective study in Vojvodina, Serbia. J Forensic Sci. 2014; 59(5):1280-5. [DOI:10.1111/1556-4029.12425] [PMID]
Wang M, Shen J, Liu X, Deng Y, Li J, Finch E, et al. Reliability and validity of the Treatment Outcome Profile among patients attending methadone maintenance treatment programs in Kunming, China. J Subst Abuse Treat. 2017; 77:89-94. [DOI:10.1016/j.jsat.2017.03.004] [PMID]
Nielsen MKK, Johansen SS, Linnet K. Evaluation of poly-drug use in methadone-related fatalities using segmental hair analysis. Forensic Sci Int. 2015; 248:134-9. [DOI:10.1016/j.forsciint.2015.01.004] [PMID]
Alinejad S, Zamani N, Abdollahi M, Mehrpour O. A narrative review of acute adult poisoning in Iran. Iran J Med Sci. 2017; 42(4):327-46. [PMID] [PMCID]
Vignali C, Stramesi C, Morini L, Pozzi F, Groppi A. Methadone-related deaths. A ten year overview. Forensic Sci Int. 2015; 257:172-6. [DOI:10.1016/j.forsciint.2015.08.017] [PMID]
Rönkä S, Katainen A. Non-medical use of prescription drugs among illicit drug users: A case study on an online drug forum. Int J Drug Policy. 2017; 39:62-8. [DOI:10.1016/j.drugpo.2016.08.013] [PMID]
Pirdehghan A, Mahmoodi S, Seifrabie MA, Haghighi M. Prevalence of substance abuse among high school students in Hamedan, Iran in 2015. Avicenna J Neuro Psycho Physiology. 2019; 6(2):67-74. [DOI:10.32598/ajnpp.4.3.295]
Akhgari M, Jokar F, Etemadi Aleagha A. Drug related deaths in Tehran, Iran: Toxicological, death and crime scene investigations. Iran J Toxicol. 2011; 5(1,2):402-9. http://ijt.arakmu.ac.ir/article-1-34-en.html
Alammehrjerdi Z, Ezard N, Dolan K. Methamphetamine dependence in methadone treatment services in Iran: The first literature review of a new health concern. Asian J Psychiatr. 2018; 31:49-55. [DOI:10.1016/j.ajp.2018.01.001] [PMID]
Alam-Mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country. Asian J Psychiatr. 2015; 16:17-25. [DOI:10.1016/j.ajp.2015.05.036] [PMID]
Amini N, Etemadi-Aleagh A, Akhgari M. Impurity profiling of street methamphetamine samples seized in Kermanshah, Iran with special focus on methamphetamine impurities health hazards. J Clin Toxicol. 2015; 5(4):1000258. https://www.longdom.org/abstract/impurity-profiling-of-street-methamphetamine-samples-seized-in-kermanshahiran-with-special-focus-on-methamphetamine-impu-50346.html
Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M. Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence. Int J Drug Policy. 2015; 26(9):808-19. [DOI:10.1016/j.drugpo.2015.04.018] [PMID] [PMCID]
Shekari A, Akhgari M, Jokar F, Mousavi Z. Impurity characteristics of street methamphetamine crystals seized in Tehran, Iran. J Subst Use. 2016; 21(5):501-5. [DOI:10.3109/14659891.2015.1068389]
- Abstract Viewed: 89 times
- PDF Downloaded: 53 times